Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Asami

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
BMC Psychiatry|March 3, 2023
Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophreniaSaki Hattori, Akira Suda, Ikuko Kishida, et al.
Plos One|November 10, 2022
The psychological distress and suicide-related ideation in hospital workers during the COVID-19 pandemic: Second results from repeated cross-sectional surveysKeiko Ide, Takeshi Asami, Akira Suda, et al.
BMC Medical Education|February 11, 2025
Enhancing clinical reasoning skills in medical students through team-based learning: a mixed-methods studyKosuke Ishizuka, Kiyoshi Shikino, Naoko Takada, et al.
Plos One|January 11, 2021
The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise shipKeiko Ide, Takeshi Asami, Akira Suda, et al.
Brain Imaging and Behavior|March 2, 2017
Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophreniaYukiko Saito, Marek Kubicki, Inga Koerte, et al.
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Contemporary Clinical Trials|October 15, 2021
Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodologyTaishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, et al.
Psychiatry and Clinical Neurosciences|December 16, 2023
Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: A 24-week randomized controlled trialTaishiro Kishimoto, Shotaro Kinoshita, Momoko Kitazawa, et al.
Frontiers in Neural Circuits|August 20, 2025
Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distributionSakiko Tsugawa, Yuichi Kimura, Junichi Chikazoe, et al.
Molecular Psychiatry|October 15, 2024
Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomographyMai Hatano, Waki Nakajima, Hideaki Tani, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
BMC Psychiatry|March 3, 2023
Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophreniaSaki Hattori, Akira Suda, Ikuko Kishida, et al.
Plos One|November 10, 2022
The psychological distress and suicide-related ideation in hospital workers during the COVID-19 pandemic: Second results from repeated cross-sectional surveysKeiko Ide, Takeshi Asami, Akira Suda, et al.
BMC Medical Education|February 11, 2025
Enhancing clinical reasoning skills in medical students through team-based learning: a mixed-methods studyKosuke Ishizuka, Kiyoshi Shikino, Naoko Takada, et al.
Plos One|January 11, 2021
The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise shipKeiko Ide, Takeshi Asami, Akira Suda, et al.
Brain Imaging and Behavior|March 2, 2017
Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophreniaYukiko Saito, Marek Kubicki, Inga Koerte, et al.
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Contemporary Clinical Trials|October 15, 2021
Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodologyTaishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, et al.
Psychiatry and Clinical Neurosciences|December 16, 2023
Live two-way video versus face-to-face treatment for depression, anxiety, and obsessive-compulsive disorder: A 24-week randomized controlled trialTaishiro Kishimoto, Shotaro Kinoshita, Momoko Kitazawa, et al.
Frontiers in Neural Circuits|August 20, 2025
Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distributionSakiko Tsugawa, Yuichi Kimura, Junichi Chikazoe, et al.
Molecular Psychiatry|October 15, 2024
Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomographyMai Hatano, Waki Nakajima, Hideaki Tani, et al.
Pageof 7